Document Details
Form
Filing Date
May 08, 2024
Document Date
May 06, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
Cormorant Asset Management, LP
